Ellipses Pharma

A drug development company focused on accelerating the development of cancer treatments through an innovative drug development model that combines unbiased vetting, to de-risk initial asset selection with an uninterrupted funding flow, to minimize the time it takes to advance lead products through clinical trials and reach patients.